A prospective study to determine the minimal biologic drug serum trough concentration required to maintain stable disease activity in psoriasis.
Phase of Trial: Phase IV
Latest Information Update: 24 Jun 2013
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Pharmacogenomic; Pharmacokinetics; Therapeutic Use
- 24 Jun 2013 New trial record